[Endocrine disorders in patients with arthritis rheumatoid].
Nagataki
S
S
D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D017209:Apoptosis; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000378:metabolism; D001851:Bone Diseases, Metabolic / Q000209:etiology / Q000517:prevention & control; D001842:Bone and Bones / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism / Q000502:physiology; D004700:Endocrine System Diseases / Q000209:etiology*; D006801:Humans; D013256:Steroids; D013583:Synovial Membrane / Q000166:cytology
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D013256:Steroids